| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.6136 | 50 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.6515 | 47 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.1243 | 28 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.5315 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.4448 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.3123 | 49 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 52.4384 | 55 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.6098 | 16 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.8952 | 32 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.1976 | 38 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 54.6774 | 59 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.2004 | 52 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.9621 | 58 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.4935 | 50 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.9228 | 48 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.276 | 49 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.7308 | 26 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.7342 | 40 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.8709 | 17 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.8827 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.9431 | 36 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.6071 | 47 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.4676 | 50 |